Requires disclosure, in such form as the superintendent shall require, of non-confidential information regarding step therapy override requests and determinations on a website that is readily accessible to the public.
Summary
Bill A02327 aims to enhance transparency in the healthcare system by mandating health care plans and utilization review agents to disclose detailed information regarding step therapy override requests and determinations. Specifically, the bill requires annual reporting to the relevant department, including data on the number of requests received, the specialties of healthcare providers submitting these requests, and the outcomes of these requests, such as approvals and denials. Additionally, the bill mandates that this information be made publicly accessible through a website or web-based tool, ensuring that patients and healthcare professionals can easily access this data.
Impact
The passage of Bill A02327 will amend existing insurance and public health laws in New York, creating new requirements for health care plans and utilization review agents. This will likely lead to increased accountability in the approval process for step therapy protocols, as insurers will need to provide clear data on their decision-making processes. The bill aims to empower patients and healthcare providers by providing them with essential information that can influence treatment decisions and improve patient care.
Sentiment
The sentiment surrounding Bill A02327 appears to be generally positive, as it addresses concerns regarding transparency and patient rights in the healthcare system. However, there may be some apprehension from insurance companies regarding the administrative burden of compliance and the potential implications of increased scrutiny over their decision-making processes.
Contention
Notable points of contention may arise from insurance companies and healthcare providers regarding the feasibility and implications of the reporting requirements. Insurers may argue that the additional reporting could lead to increased operational costs and complexities, while healthcare providers may express concerns about the adequacy of the information provided and how it may impact patient care. The balance between transparency and operational efficiency is likely to be a key debate point.
Same As
Requires disclosure, in such form as the superintendent shall require, of non-confidential information regarding step therapy override requests and determinations on a website that is readily accessible to the public.
Requires disclosure, in such form as the superintendent shall require, of non-confidential information regarding step therapy override requests and determinations on a website that is readily accessible to the public.
Requires disclosure, in such form as the superintendent shall require, of non-confidential information regarding step therapy override requests and determinations on a website that is readily accessible to the public.
Requires disclosure, in such form as the superintendent shall require, of non-confidential information regarding step therapy override requests and determinations on a website that is readily accessible to the public.
Amends provisions relative to confidentiality of health care communications and the process for requesting records and/or confidential health care information.
Amends provisions relative to confidentiality of health care communications and the process for requesting records and/or confidential health care information.
Amends provisions relative to confidentiality of health care communications and the process for requesting records and/or confidential health care information.
Requires agencies subject to FOIL requirements to promulgate rules and regulations regarding to whom a requestor may appeal a denial and how to request records from or appeal a denial; makes certain provisions relating to publication of contact information for FOIL requests and appeals.
Drains: appeals; period to appeal apportionment or assessment costs on drain projects; modify. Amends secs. 72 & 72a of 1956 PA 40 (MCL 280.72 & 280.72a).